Study of Recombinant Carboxypeptidase G2 (CPG2) for the Management of Patients With Delayed Methotrexate (MTX) Clearance or Intrathecal MTX Overdosage
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Reduction in serum MTX concentration
Thiel Eckhard, Prof. Dr.med.
Charite - Universitätsmedizin Berlin
Germany: Federal Institute for Drugs and Medical Devices